tk88 bet

Vietnam approves national programme for development of domestic vaccines

Deputy Prime Minister Vu Duc Dam has approved a national science-technology programme for promoting studies and production of human vaccines by 2030.
Vietnam approves national programme for development of domestic vaccines ảnh 1Illustrative photo. (Source: VNA)

Hanoi (VNA) – Deputy Prime Minister Vu Duc Dam has approved a national science-technology programme for promoting studies and production of human vaccines by 2030.

The programme aims to clear the way for Vietnam to master technologies for vaccine production and build capacity of domestic organisations and companies specialized in vaccine R&D and production in order to improve its preparedness to potential epidemics in the future.

Under the programme, the production of all domestic vaccines will meet international standards and sufficiently supply the National Expanded Programme on Immunisation. The country also looks forward to exporting its home-grown vaccines.

By 2025, Vietnam is expected to own production technologies of at least 10 vaccines and produce at least three. The figures will reach 15 and five, respectively, by 2030.

Vietnam approves national programme for development of domestic vaccines ảnh 2COVIVAC vaccine is a COVID-19 vaccine candidate developed by the Health Ministry's Institute of Vaccines and Medical Biologicals (IVAC). (Photo: VNA)

To this end, the programme will improve legal framework and amend legal documents for the acceleration of development, trial and approval of domestic vaccines. It will also promote the use of both latest and conventional technologies for producing vaccines against COVID-19, cancers and others.

𓆏 The Ministry of Science and Technology has been assigned to coordinate with the Ministry of Health and relevant ministries and agencies to implement the programme. The Ministry of Health, meanwhile, is responsible for creating all possible conditions for developers to conduct studies, clinical trials, verification and approval of vaccines./.

VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

♌ Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

𒁃 Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

♍ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|